APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bio-based Polyfarnesene

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bio-based Polyfarnesene Market Outlook and Growth Opportunities 2026

20 December 2025194 pages

Choose your research edition.

Industry ResearchBio-based Polyfarnesene Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Bio-based Polyfarnesene Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Bio-based Polyfarnesene Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bio-based Polyfarnesene Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Bio-based Polyfarnesene Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Bio-based Polyfarnesene market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bio-based Polyfarnesene is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bio-based Polyfarnesene is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bio-based Polyfarnesene is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bio-based Polyfarnesene market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bio-based Polyfarnesene market include Cray Valley and Kuraray among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bio-based Polyfarnesene market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bio-based Polyfarnesene and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bio-based Polyfarnesene sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bio-based Polyfarnesene market size, projected growth trends, production technologies, key applications, and end-use industries.

Bio-based Polyfarnesene Segment by Company

Cray Valley

Kuraray

Bio-based Polyfarnesene Segment by Type

Homopolymer Type

Random Copolymer Type

Bio-based Polyfarnesene Segment by Application

Adhesives

Rubber Applications

Cosmetics Applications

Others

Bio-based Polyfarnesene Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Bio-based Polyfarnesene status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bio-based Polyfarnesene market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bio-based Polyfarnesene significant trends, drivers, influence factors in global and regions.

6. To analyze Bio-based Polyfarnesene competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio-based Polyfarnesene market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bio-based Polyfarnesene and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio-based Polyfarnesene.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bio-based Polyfarnesene market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bio-based Polyfarnesene industry.

Chapter 3: Detailed analysis of Bio-based Polyfarnesene manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bio-based Polyfarnesene in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bio-based Polyfarnesene in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bio-based Polyfarnesene Industry Trends Table 2. Bio-based Polyfarnesene Industry Drivers Table 3. Bio-based Polyfarnesene Industry Opportunities and Challenges Table 4. Bio-based Polyfarnesene Industry Restraints Table 5. Global Bio-based Polyfarnesene Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bio-based Polyfarnesene Revenue Share by Company (2021-2026) Table 7. Global Bio-based Polyfarnesene Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Bio-based Polyfarnesene Sales Volume Share by Company (2021-2026) Table 9. Global Bio-based Polyfarnesene Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Bio-based Polyfarnesene Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bio-based Polyfarnesene Key Company Manufacturing Base & Headquarters Table 12. Global Bio-based Polyfarnesene Company, Product Type & Application Table 13. Global Bio-based Polyfarnesene Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bio-based Polyfarnesene by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Homopolymer Type Table 18. Significant Companies of Random Copolymer Type Table 19. Global Bio-based Polyfarnesene Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Bio-based Polyfarnesene Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Bio-based Polyfarnesene Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Bio-based Polyfarnesene Sales Volume Share by Type (2021-2026) Table 23. Global Bio-based Polyfarnesene Sales Volume Share by Type (2027-2032) Table 24. Global Bio-based Polyfarnesene Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bio-based Polyfarnesene Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Bio-based Polyfarnesene Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Bio-based Polyfarnesene Sales Value Share by Type (2021-2026) Table 28. Global Bio-based Polyfarnesene Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Adhesives Table 30. Significant Companies of Rubber Applications Table 31. Significant Companies of Cosmetics Applications Table 32. Significant Companies of Others Table 33. Global Bio-based Polyfarnesene Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Bio-based Polyfarnesene Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Bio-based Polyfarnesene Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Bio-based Polyfarnesene Sales Volume Share by Application (2021-2026) Table 37. Global Bio-based Polyfarnesene Sales Volume Share by Application (2027-2032) Table 38. Global Bio-based Polyfarnesene Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Bio-based Polyfarnesene Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Bio-based Polyfarnesene Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Bio-based Polyfarnesene Sales Value Share by Application (2021-2026) Table 42. Global Bio-based Polyfarnesene Sales Value Share by Application (2027-2032) Table 43. Global Bio-based Polyfarnesene Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Bio-based Polyfarnesene Sales by Region (2021-2026) & (Tons) Table 45. Global Bio-based Polyfarnesene Sales Market Share by Region (2021-2026) Table 46. Global Bio-based Polyfarnesene Sales by Region (2027-2032) & (Tons) Table 47. Global Bio-based Polyfarnesene Sales Market Share by Region (2027-2032) Table 48. Global Bio-based Polyfarnesene Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Bio-based Polyfarnesene Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Bio-based Polyfarnesene Sales Value Share by Region (2021-2026) Table 51. Global Bio-based Polyfarnesene Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Bio-based Polyfarnesene Sales Value Share by Region (2027-2032) Table 53. Global Bio-based Polyfarnesene Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Bio-based Polyfarnesene Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Bio-based Polyfarnesene Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Bio-based Polyfarnesene Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Bio-based Polyfarnesene Sales by Country (2021-2026) & (Tons) Table 58. Global Bio-based Polyfarnesene Sales Market Share by Country (2021-2026) Table 59. Global Bio-based Polyfarnesene Sales by Country (2027-2032) & (Tons) Table 60. Global Bio-based Polyfarnesene Sales Market Share by Country (2027-2032) Table 61. Global Bio-based Polyfarnesene Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Bio-based Polyfarnesene Sales Value Market Share by Country (2021-2026) Table 63. Global Bio-based Polyfarnesene Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Bio-based Polyfarnesene Sales Value Market Share by Country (2027-2032) Table 65. Cray Valley Company Information Table 66. Cray Valley Business Overview Table 67. Cray Valley Bio-based Polyfarnesene Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Cray Valley Bio-based Polyfarnesene Product Portfolio Table 69. Cray Valley Recent Development Table 70. Kuraray Company Information Table 71. Kuraray Business Overview Table 72. Kuraray Bio-based Polyfarnesene Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Kuraray Bio-based Polyfarnesene Product Portfolio Table 74. Kuraray Recent Development Table 75. Key Raw Materials Table 76. Raw Materials Key Suppliers Table 77. Bio-based Polyfarnesene Distributors List Table 78. Bio-based Polyfarnesene Customers List Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Bio-based Polyfarnesene Product Image Figure 2. Global Bio-based Polyfarnesene Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bio-based Polyfarnesene Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bio-based Polyfarnesene Sales (2021-2032) & (Tons) Figure 5. Global Bio-based Polyfarnesene Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Bio-based Polyfarnesene Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Homopolymer Type Image Figure 10. Random Copolymer Type Image Figure 11. Global Bio-based Polyfarnesene Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Bio-based Polyfarnesene Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Bio-based Polyfarnesene Sales Volume Share by Type (2021-2032) Figure 14. Global Bio-based Polyfarnesene Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bio-based Polyfarnesene Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bio-based Polyfarnesene Sales Value Share by Type (2021-2032) Figure 17. Adhesives Image Figure 18. Rubber Applications Image Figure 19. Cosmetics Applications Image Figure 20. Others Image Figure 21. Global Bio-based Polyfarnesene Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Bio-based Polyfarnesene Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Bio-based Polyfarnesene Sales Volume Share by Application (2021-2032) Figure 24. Global Bio-based Polyfarnesene Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Bio-based Polyfarnesene Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Bio-based Polyfarnesene Sales Value Share by Application (2021-2032) Figure 27. Global Bio-based Polyfarnesene Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Bio-based Polyfarnesene Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Bio-based Polyfarnesene Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Bio-based Polyfarnesene Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Bio-based Polyfarnesene Sales Value (2021-2032) & (US$ Million) Figure 32. North America Bio-based Polyfarnesene Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Bio-based Polyfarnesene Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Bio-based Polyfarnesene Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Bio-based Polyfarnesene Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Bio-based Polyfarnesene Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Bio-based Polyfarnesene Sales Value (2021-2032) & (US$ Million) Figure 38. South America Bio-based Polyfarnesene Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Bio-based Polyfarnesene Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Bio-based Polyfarnesene Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Bio-based Polyfarnesene Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Bio-based Polyfarnesene Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Homopolymer Type
  • Random Copolymer Type
Applications
  • Adhesives
  • Rubber Applications
  • Cosmetics Applications
  • Others
Companies covered
  • Cray Valley
  • Kuraray

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bio-based Polyfarnesene Sales Value (2021-2032)
  4. 1.2.2 Global Bio-based Polyfarnesene Sales Volume (2021-2032)
  5. 1.2.3 Global Bio-based Polyfarnesene Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bio-based Polyfarnesene Market Dynamics
  1. 2.1 Bio-based Polyfarnesene Industry Trends
  2. 2.2 Bio-based Polyfarnesene Industry Drivers
  3. 2.3 Bio-based Polyfarnesene Industry Opportunities and Challenges
  4. 2.4 Bio-based Polyfarnesene Industry Restraints
3 Bio-based Polyfarnesene Market by Company
  1. 3.1 Global Bio-based Polyfarnesene Company Revenue Ranking in 2025
  2. 3.2 Global Bio-based Polyfarnesene Revenue by Company (2021-2026)
  3. 3.3 Global Bio-based Polyfarnesene Sales Volume by Company (2021-2026)
  4. 3.4 Global Bio-based Polyfarnesene Average Price by Company (2021-2026)
  5. 3.5 Global Bio-based Polyfarnesene Company Ranking (2024-2026)
  6. 3.6 Global Bio-based Polyfarnesene Company Manufacturing Base and Headquarters
  7. 3.7 Global Bio-based Polyfarnesene Company Product Type and Application
  8. 3.8 Global Bio-based Polyfarnesene Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bio-based Polyfarnesene Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bio-based Polyfarnesene Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bio-based Polyfarnesene Market by Type
  1. 4.1 Bio-based Polyfarnesene Type Introduction
  2. 4.1.1 Homopolymer Type
  3. 4.1.2 Random Copolymer Type
  4. 4.2 Global Bio-based Polyfarnesene Sales Volume by Type
  5. 4.2.1 Global Bio-based Polyfarnesene Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bio-based Polyfarnesene Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Bio-based Polyfarnesene Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Bio-based Polyfarnesene Sales Value by Type
  9. 4.3.1 Global Bio-based Polyfarnesene Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bio-based Polyfarnesene Sales Value by Type (2021-2032)
  11. 4.3.3 Global Bio-based Polyfarnesene Sales Value Share by Type (2021-2032)
5 Bio-based Polyfarnesene Market by Application
  1. 5.1 Bio-based Polyfarnesene Application Introduction
  2. 5.1.1 Adhesives
  3. 5.1.2 Rubber Applications
  4. 5.1.3 Cosmetics Applications
  5. 5.1.4 Others
  6. 5.2 Global Bio-based Polyfarnesene Sales Volume by Application
  7. 5.2.1 Global Bio-based Polyfarnesene Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Bio-based Polyfarnesene Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Bio-based Polyfarnesene Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Bio-based Polyfarnesene Sales Value by Application
  11. 5.3.1 Global Bio-based Polyfarnesene Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Bio-based Polyfarnesene Sales Value by Application (2021-2032)
  13. 5.3.3 Global Bio-based Polyfarnesene Sales Value Share by Application (2021-2032)
6 Bio-based Polyfarnesene Regional Sales and Value Analysis
  1. 6.1 Global Bio-based Polyfarnesene Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bio-based Polyfarnesene Sales by Region (2021-2032)
  3. 6.2.1 Global Bio-based Polyfarnesene Sales by Region: 2021-2026
  4. 6.2.2 Global Bio-based Polyfarnesene Sales by Region (2027-2032)
  5. 6.3 Global Bio-based Polyfarnesene Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bio-based Polyfarnesene Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bio-based Polyfarnesene Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bio-based Polyfarnesene Sales Value by Region (2027-2032)
  9. 6.5 Global Bio-based Polyfarnesene Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bio-based Polyfarnesene Sales Value (2021-2032)
  12. 6.6.2 North America Bio-based Polyfarnesene Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bio-based Polyfarnesene Sales Value (2021-2032)
  15. 6.7.2 Europe Bio-based Polyfarnesene Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bio-based Polyfarnesene Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bio-based Polyfarnesene Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bio-based Polyfarnesene Sales Value (2021-2032)
  21. 6.9.2 South America Bio-based Polyfarnesene Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bio-based Polyfarnesene Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bio-based Polyfarnesene Sales Value Share by Country, 2025 VS 2032
7 Bio-based Polyfarnesene Country-level Sales and Value Analysis
  1. 7.1 Global Bio-based Polyfarnesene Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bio-based Polyfarnesene Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bio-based Polyfarnesene Sales by Country (2021-2032)
  4. 7.3.1 Global Bio-based Polyfarnesene Sales by Country (2021-2026)
  5. 7.3.2 Global Bio-based Polyfarnesene Sales by Country (2027-2032)
  6. 7.4 Global Bio-based Polyfarnesene Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bio-based Polyfarnesene Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bio-based Polyfarnesene Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bio-based Polyfarnesene Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bio-based Polyfarnesene Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bio-based Polyfarnesene Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cray Valley
  2. 8.1.1 Cray Valley Company Information
  3. 8.1.2 Cray Valley Business Overview
  4. 8.1.3 Cray Valley Bio-based Polyfarnesene Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cray Valley Bio-based Polyfarnesene Product Portfolio
  6. 8.1.5 Cray Valley Recent Developments
  7. 8.2 Kuraray
  8. 8.2.1 Kuraray Company Information
  9. 8.2.2 Kuraray Business Overview
  10. 8.2.3 Kuraray Bio-based Polyfarnesene Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Kuraray Bio-based Polyfarnesene Product Portfolio
  12. 8.2.5 Kuraray Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bio-based Polyfarnesene Value Chain Analysis
  2. 9.1.1 Bio-based Polyfarnesene Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bio-based Polyfarnesene Sales Mode & Process
  6. 9.2 Bio-based Polyfarnesene Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bio-based Polyfarnesene Distributors
  9. 9.2.3 Bio-based Polyfarnesene Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst